دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients
Landen Shane Burstiner, DO, MSc,*,†Anna H. Owings, DO, ‡,§ Amor Royer, MD,‡ Yousef Hreish, MD,‡ Jeshanah Johnson, MD,‡ Madelyn Barr, MD,‡ Hannah Laird, BS, ‡ Spurthi Tarugu, MD,‡ Kane Edwards, MD,‡ Lauren Bradley, MD,‡ Himmat Brar, MD,‡,§ Tanya O. Robinson, PhD, § Pegah Hosseini-Carroll, MD, § Julia Liu, MD, MSc,¶ and Sarah C. Glover, DO
doi : 10.1093/ibd/izad005
Volume 29, Issue 12, December 2023
Pro-inflammatory Cytokines Promote the Occurrence and Development of Colitis-associated Colorectal Cancer by Inhibiting miR-615-5p
Danping Sun, MD, * Lingqi Gong, MD, †Xiaotong Wang, MD, * Shuijiao Chen, PhD, *,‡,§ Jun Yi, MD, *,‡,§ and Xiaowei Liu, MD, PhD
doi : 10.1093/ibd/izad105
Preoperative Simulation of Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis Using a 3-Dimensional Printed Model
Shota Yokose, MD , Koji Murono, MD, PhD, Hiroaki Nozawa, MD, PhD , Kazuhito Sasaki, MD, PhD, Shigenobu Emoto, MD, PhD, Hiroyuki Matsuzaki, MD, PhD, Yuichiro Yokoyama, MD, PhD, Shinya Abe, MD, PhD, Yuzo Nagai, MD, PhD, Yuichiro Yoshioka, MD, PhD, Takahide Shinagawa, MD, PhD, Hirofumi Sonoda, MD, PhD, Shin Murai, MD, Koichi Komatsu, MD, and Soichiro Ishihara, MD, PhD
doi : 10.1093/ibd/izac283
Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease
Noreen Singh, MSc, MD,* Zoann Nugent, PhD, †Harminder Singh, MD, MPH,*,†,‡, Seth R. Shaffer, MD,*,†and Charles N. Bernstein, MD
doi : 10.1093/ibd/izad017
The Prevalence of Inflammatory Bowel Disease in Greenland
Rasmus Hvidbjerg Gantzel, MD,*,†,‡, Jos Dalvad Vesterdal MD,§ Anne-Mette Haase, MD, PhD, †Alice Juhl Petersen, MD,§ Henning Gr?nb?k, MD, PhD,†,‡ and Michael Lynge Pedersen, MD, PhD, MSc
doi : 10.1093/ibd/izad002
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study
Laura Sempere,*, Purificaci?n Bernabeu,†José Cameo,* Ana Gutiérrez,* Mar?a Gloria Garc?a,‡ Mariana Fe Garc?a,§ Mariam Aguas,¶ Olivia Belén,* Pedro Zapater,? Rodrigo Jover,* Carlos van-der Hofstadt, †Mar?a Teresa Ruiz-Cantero
doi : 10.1093/ibd/izad001
Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn’s Disease
Furkan U. Ertem, MD,*, Claudia Ramos Rivers,* Andrew R. Watson, MD †Gong Tang, PhD, ‡ Marc Schwartz, MD,* Elyse Johnston, MD,* Arthur Barrie, MD, PhD, ‡ Janet Harrison, MD, ‡ Jeffrey M. Dueker, MD, MPH,* Doug Hartman, MD,* David G. Binion, MD*
doi : 10.1093/ibd/izad008
Automatized Detection of Crohn’s Disease in Intestinal Ultrasound Using Convolutional Neural Network
Dan Carter, MD,*,†, Ahmed Albshesh, MD,*,†Carmi Shimon, MSc,‡ Batel Segal,‡ Alex Yershov, BS,‡ Uri Kopylov, MD,*,†Adele Meyers, BS, ‡ Rafael Y. Brzezinski, BS, ‡ Shomron Ben Horin, MD,*,†and Oshrit Hoffer, PHD
doi : 10.1093/ibd/izad014
Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis
Maia Kayal, MD MS,*, Hannah Posner, BS,* Hadar Meringer Milwidsky, MD,* Michael Plietz, MD,†Sergey Khaitov, MD,†Patricia Sylla, MD,†Alexander Greenstein, MD MPH, †Marla C. Dubinsky, MD,* Saurabh Mehandru, MD,* and Jean Frederic Colombel, MD
doi : 10.1093/ibd/izad039
A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow–Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn’s Disease
Amy L. Lightner, MD,*, Ana Otero-Pineiro, MD, PhD,* Jane Reese, MBA,†Justin Ream, MD,‡ Douglas Nachand, MD, ‡ Ashley C. Adams, NP,* Alexandra VanDenBossche, NP,* and Jacob A. Kurowski, MD
doi : 10.1093/ibd/izad100
Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease
Natsuki Ito, MD,*,†Takahiro Kudo , MD, PhD,*, Hidetaka Eguchi, PhD, †Keisuke Jimbo, MD, PhD,* Atsushi Furuhata, PhD,‡ Toshiaki Okuno , PhD,§, Ichiro Takeuchi, MD,¶ Katsuhiro Arai, MD, PhD,¶ Takashi Ishige, MD, PhD,? Yasushi Okazaki, MD, PhD, †Toshiaki Shimizu, MD, PhD
doi : 10.1093/ibd/izad116
SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis
Xiaotian Chen, MD, PhD,*,†,# Mingming Zhang, PhD,‡,# Fan Zhou, PhD, §,# Zhengrong Gu, MD,¶,# Yuan Li, PhD,* Ting Yu , PhD,? Chunyan Peng, PhD, § Lixing Zhou, PhD,** Xiangrui Li, BD, MD student,* Dandan Zhu, BD, MD student,§ Xiaoqi Zhang, PhD,§ and Chenggong Yu, PhD
doi : 10.1093/ibd/izad099
CircASPH Enhances Exosomal STING to Facilitate M2 Macrophage Polarization in Colorectal Cancer
Yuting Zhang, MD,*,# Jiakun Guo, BEng,†,# Liyin Zhang, MD, ‡ Ying Li, PhD, § Kangliang Sheng, PhD,¶ Yawei Zhang, MD,? Liu Liu, PhD,** Wenbin Gong, PhD, ††and Kun Guo, PhD
doi : 10.1093/ibd/izad113
Depression in Women With Inflammatory Bowel Disease: A Multifaceted Approach for a Multidimensional Problem
Shoma Bommena, MD,*, Aaron Goldberg, MD, †Mona Amini, MD,‡ and Yasmin Alishahi, MD
doi : 10.1093/ibd/izac245
Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis
Dorina Bajz?t, MD,*,†Adrienn F. Kéri, MD,*,†Marcell Imrei, MD,*,†Tam?s K?i , PhD,*,‡ Andrea P?rniczky, MD, PhD,*,†,§ Péter Hegyi, MD, PhD, DSc,*,§,¶ Kinga Kov?cs, MD,*,? Szil?rd V?ncsa, MD,* Katalin Eszter Müller, MD, PhD
doi : 10.1093/ibd/izac274
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease
Amalia Di Petrillo, PhD, * Amit Kumar, PhD, †Sara Onali, MD, PhD, * Agnese Favale, MD, * and Massimo Claudio Fantini, MD, PhD
doi : 10.1093/ibd/izad161
Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows
Badr Al-Bawardy, MD,*,†, Lisa Malter, MD,‡ Adam C. Ehrlich, MD, § Florian Rieder, MD,¶ Jill K. J. Gaidos, MD,* Deborah Proctor, MD,* and Donna M. Windish, MD
doi : 10.1093/ibd/izad030
Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases
Ghadeer K. Dawwas, PhD,* Alexandra Weiss, MD, †Brad D. Constant, MD, MSCS,‡ Lauren E. Parlett, PhD, § Kevin Haynes, PhD, ¶ Jeff Yufeng Yang, PhD, ? Colleen Brensinger, MS,* Qufei Wu, MS,* Virginia Pate , MS,? Michele Jonsson Funk, PhD,? Douglas E. Schaubel, PhD,** Andres Hurtado-Lorenzo, PhD, ††Michael David Kappelman, MD, MPH,‡‡ James D. Lewis, MD, MSCE
doi : 10.1093/ibd/izad053
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis
Noa Krugliak Cleveland, MD,* Yusuke Miyatani, MD, * Emma A. Picker, BA,* and David T. Rubin, MD
doi : 10.1093/ibd/izad237
3D Imaging and Printing in Inflammatory Bowel Diseases: Limitations, Barriers, and Opportunities Toward “Haute Couture� Surgical Approaches
Gianluca Pellino*,†, and Alvaro Garc?a-Granero
doi : 10.1093/ibd/izad086
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study
Loren G. Rabinowitz
doi : 10.1093/ibd/izad047
Shedding New Light on High-Risk Phenotypes for Pouchitis
Edward L. Barnes, MD, MPH,*,†,‡, and Shannon Chang, MD, MBA
doi : 10.1093/ibd/izad027
The Rational Use of Advanced Therapies for Inflammatory Conditions of the Pouch
Edward L. Barnes, MD, MPH,*,†,‡, Maia Kayal, MD,§, and David M. Schwartzberg, MD
doi : 10.1093/ibd/izad264
Correction to: Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response
doi : 10.1093/ibd/izad239
Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn’s Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
doi : 10.1093/ibd/izad260
Correction to: Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission
doi : 10.1093/ibd/izad261
Correction to: Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines
doi : 10.1093/ibd/izad271
